Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Functional inspiratory muscle and core stabilization training for people with post-COVID-19 syndrome

Official title: Investigation of the Effects of Functional Respiratory Muscle Training on Respiratory Muscle Function, Exercise Capacity, Skeletal Muscle Strength, and Muscle Endurance in Individuals With Post-COVID-19 Syndrome

Run by Hacettepe University · NCT07051954 · Data updated 2026-11-12

This trial will test whether adding inspiratory muscle training to core stabilization helps adults with post-COVID-19 syndrome improve breathing strength, trunk endurance, exercise capacity, and symptoms like fatigue and breathlessness.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment40 (estimated)
SponsorHacettepe University
Academic / other
Locations1 site (Ankara, Çankaya)
StatusRecruiting
StartedSeptember 15, 2025
Main results expectedDecember 1, 2026
Study endsDecember 30, 2026
Registry record updatedJanuary 14, 2026
Trial IDNCT07051954 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–65 with a diagnosis of post-COVID-19 syndrome, PCFS functional class 2–3, who are clinically stable, literate in Turkish, and without orthopedic or neurological impairments that would limit participation.

Probably not a fit

People with recent myocardial infarction or pulmonary embolism, uncontrolled chronic diseases, severe neurological or psychiatric disorders, major mobility-limiting orthopedic problems, or those outside the 18–65 age range are unlikely to benefit or will be excluded.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults with post-COVID-19 syndrome will be randomized to 8 weeks of core stabilization exercises alone or core stabilization combined with functional inspiratory muscle training, with sessions three times weekly lasting about 50 minutes. Comprehensive pre- and post-intervention assessments include exercise capacity, respiratory and peripheral muscle strength, trunk endurance, balance, and measures of anxiety, depression, and fatigue. Primary outcomes are respiratory muscle strength and trunk muscle endurance, and randomization is stratified by key variables using computer-assisted methods. Participants are aged 18–65, Turkish-speaking, literate, clinically stable, and classified as PCFS functional class 2–3.

Why it matters

Potential benefit: If successful, the combined program could strengthen breathing muscles and trunk endurance, boost exercise capacity, and reduce fatigue and mood symptoms in people with post-COVID-19 syndrome.

How similar studies have gone: Smaller trials and rehabilitation programs using inspiratory muscle training and core exercises in respiratory disease and preliminary post-COVID cohorts have reported improvements in respiratory strength and symptoms, but large randomized data are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Diagnosed with Post-COVID-19 Syndrome.
* Literate and able to understand study procedures.
* Aged between 18 and 65 years.
* Willing to voluntarily participate in the study.
* Classified as functional class 2-3 according to the Post-COVID-19 Functional Status Scale (PCFS).
* Clinically stable; comorbid conditions such as hypertension or diabetes must be controlled.
* No orthopedic or neurological conditions that would prevent assessment of peripheral muscle strength, balance, or exercise capacity.

Exclusion Criteria:

* History of recent myocardial infarction or pulmonary embolism.
* Presence of uncontrolled chronic diseases.
* Any orthopedic or neurological disorders that limit mobility.
* Neurological impairments (e.g., cerebrovascular disease) or psychiatric disorders that impair cooperation or compliance with exercise testing.

Where it's running

  • Hacettepe University
    Ankara, Çankaya, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.